INTRODUCTION
============

Eosinophilic esophagitis (EoE) is characterized by eosinophilic infiltration of the esophageal mucosa, which induces various digestive symptoms. The mechanism of development of EoE is not yet completely clear \[[@B1]\]. Recent reports have indicated a rapid increase in the incidence of EoE worldwide \[[@B2][@B3]\].

EoE is often observed with other allergic diseases \[[@B1][@B2]\]. Coexistence of EoE and pollen-food allergy syndrome (PFAS) as comorbidities have been reported in adult patients \[[@B4]\]. PFAS provokes oral symptoms after ingesting particular fruits that have cross-reactivity to pollen \[[@B5]\]. The number of young children with PFAS is also increasing \[[@B6]\].

However, data on the correlation between the 2 diseases is insufficient. A previous report suggested that an association between PFAS and EoE might be present only in adults \[[@B7]\]. We herein report the case of an 8-year-old boy with EoE and PFAS.

CASE REPORT
===========

The patient was a Japanese boy with a family history of allergic rhinitis (AR) in his father and atopic dermatitis in his mother. He had had intermittent vomiting of unknown etiology since the age of 2 years. He underwent tonsillectomy at the age of 4 years because his treating physician considered tonsillar hypertrophy as the possible cause of his vomiting. However, his vomiting did not resolve after the surgery. His growth and development were appropriate for his age, but he experienced rhinorrhea and nasal congestion in winter and spring from the age of 5 years. At 7 years of age, he experienced his first episode of itchiness of the lips and throat, followed by vomiting, immediately after ingesting raw kiwifruit, cherry, and apple. When he was 8 years old, he was referred to the National Center for Child Health and Development in order to evaluate the necessity for eliminating fruits from his diet.

At this stage, he was 125.7 cm tall (--0.1 standard deviation \[SD\]) and weighed 25.6 kg (--0.2 SD). Physical examination was unremarkable, with no signs of eczema, wheezing, swollen lips, etc. Blood tests showed elevation of IgE antibodies specific for birch, apple, kiwifruit, peaches, and walnuts, the levels of all of which were above 0.35 UA/mL. Slightly elevated total IgE (215 IU/mL) levels were also noted, but hypereosinophilia was not detected (288/µL). He underwent skin prick testing for fruits and nuts, including apple, kiwifruit, cherry, and peach \[[@B8]\]. Positive results (wheal ≥ 3 mm in diameter) were observed with raw kiwifruit, raw and heated peach, raw cherry, walnut, and hazelnut ([Table 1](#T1){ref-type="table"}). Raw apple resulted in a wheal-like rash less than 3 mm in diameter. Testing with cooked apple and kiwifruit did not produce significant wheals. Based on these results and his clinical course, the patient was diagnosed with PFAS for apple, kiwifruit, and cherries. Only for peach, which is a cause of lipid transfer protein syndrome \[[@B9]\], both raw and heated antigens caused positive results. These findings led us to consider the possibility of different sensitization routes for apple, kiwifruit, and cherry, versus peach. Both the patient and his mother did not agree to oral food challenges with nuts and peach. Based on these results, we recommended elimination of apple, kiwifruits, cherry, peach, and foods that demonstrated positive results in the skin prick test. However, his vomiting did not resolve despite complete elimination of the above foods.

###### Results of allergic tests within one month of the patient's first visit to our department

![](apa-10-e28-i001)

  Antigen          Antigen-specific-IgE level (UA/mL)   Skin prick testing wheal diameter (mm)   
  ---------------- ------------------------------------ ---------------------------------------- -----------
  Japanese cedar   **17.50**                            NA                                       NA
  Ragweed          0.31                                 NA                                       NA
  Birch            **7.77**                             NA                                       NA
  Orchard grass    0.27                                 NA                                       NA
  Kiwifruit        **1.25**                             **7 × 6**                                0 × 0
  Apple            **3.34**                             2 × 2                                    0 × 0
  Peach            **1.51**                             **3 × 3**                                **5 × 4**
  Cherry           NA                                   **3 × 3**                                NA
  Mango            \<0.10                               0 × 0                                    NA
  Banana           0.20                                 NA                                       NA
  Orange           0.14                                 0 × 0                                    NA
  Melon            \<0.10                               NA                                       NA
  Watermelon       0.10                                 NA                                       NA
  Walnut           **1.69**                             **15 × 7**                               NA
  Hazelnut         NA                                   **15 × 7**                               NA
  Cashew           NA                                   0 × 0                                    NA

NA, not applicable.

Numbers in bold: sensitization, as indicated by specific IgE levels and positivity on skin prick tests. In terms of antigen-specific IgE levels, a level of 0.35 UA/mL or more was defined as sensitization. In the skin prick test, the diameter of the wheal was expressed as the longest diameter × shortest diameter (mm) and positivity was defined as a wheal diameter above 3 mm × 3 mm. Wheal diameter was expressed relative to the wheal diameter with normal saline (as a negative control) of 0 mm × 0 mm, and with histamine extract (10 mg/mL) (as a positive control) of 5 mm × 6 mm.

Eleven months after PFAS was diagnosed, an esophagogastroduodenoscopy was performed to evaluate the cause of his occasional vomiting. Longitudinal furrows and esophageal rings in the mid to lower esophagus, along with marked lymphoid follicles in the lower esophagus, were noted ([Fig. 1A](#F1){ref-type="fig"}). There were no noticeable abnormal findings in the stomach and duodenum. Eosinophilic infiltration (39 per high-power field \[HPF\]) was observed in the stratified squamous epithelium of the mid esophagus ([Fig. 1B](#F1){ref-type="fig"}), with no significant eosinophilic infiltration of the stomach and duodenum. Ileo-colonoscopy was not performed as the patient did not have diarrhea or hematochezia. Based on the findings, his condition was diagnosed as EoE and oral esomeprazole (20 mg/day) therapy was initiated \[[@B10]\]. Within a month, his vomiting had resolved, and 8 weeks later, he underwent another esophagogastroduodenoscopy to evaluate the effects of esomeprazole. This examination revealed improvement in his EoE, with very few eosinophils (0--1/HPF) in the esophageal epithelium ([Fig. 1C](#F1){ref-type="fig"}).

![Histologic examination of esophageal tissue samples (hematoxylin and eosin staining). (A) Upper gastrointestinal endoscopy showed longitudinal furrows and esophageal rings in the mid to lower esophagus, and lymphoid follicles in the lower esophagus. (B) Histological studies before initiating esomeprazole treatment showed eosinophilic infiltration of 39/high-power field (HPF) in the stratified squamous layer of the mid esophagus. (C) Eosinophilia and inflammation resolved 2 months after the start of esomeprazole (eosinophils 0--1/HPF).](apa-10-e28-g001){#F1}

This study was reviewed and approved by the review board of National Center for Child Health and Development (\#2019-008). Oral informed consent, including consent to publish the findings, was obtained from the study participant and his mother.

DISCUSSION
==========

We report here the case of a boy with PFAS complicated with EoE. An association between PFAS and EoE has been described in adults \[[@B7][@B11]\]. Mahdavinia et al. \[[@B7]\] showed that adults with EoE and AR had a higher prevalence of PFAS compared to AR patients without EoE (50.9% vs. 10.2%, *p* \< 0.001). Two possible mechanisms were proposed for this association. One hypothesis is that EoE occurs as a result of esophageal inflammation secondary to PFAS. There is a report showing an adult case of PFAS and EoE that might have been caused by continuous ingestion of the PFAS-related food; elimination of the related food improved the symptoms and histological findings of EoE \[[@B11]\]. Another hypothesis is that PFAS is caused by sensitization secondary to epithelial barrier disruption in EoE. It is possible that gastroesophageal reflux, which causes eosinophilic infiltration similar to EoE, also contributes to sensitization to aeroallergens \[[@B12]\]. EoE might also contribute to the development of PFAS by amplifying sensitization to aeroallergens.

We opined that our case might have been caused by the latter mechanism, since his long-term vomiting resolved with the use of a proton pump inhibitor, but not by elimination of PFAS-related foods. Our case and other reports suggest the possibility that EoE, AR, and PFAS can become causal risk factors for each other. Future prospective clinical studies are needed to reveal the complex interactions of these diseases.

This report is limited by the fact that the diagnosis of PFAS was not based on component-resolved diagnosis \[[@B5]\]. However, measuring component-specific IgE levels was not required for the diagnosis, since his symptoms, medical history, and test results all supported the diagnosis of PFAS.

With recent increases in various allergic disorders, pediatric cases of comorbid PFAS and EoE might increase in the near future \[[@B2][@B6]\]. Performance of esophagogastroduodenoscopy with mucosal biopsies should be considered in atypical PFAS cases with digestive symptoms.
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